Cargando…

Immunodominant proteins P1 and P40/P90 from human pathogen Mycoplasma pneumoniae

Mycoplasma pneumoniae is a bacterial human pathogen that causes primary atypical pneumonia. M. pneumoniae motility and infectivity are mediated by the immunodominant proteins P1 and P40/P90, which form a transmembrane adhesion complex. Here we report the structure of P1, determined by X-ray crystall...

Descripción completa

Detalles Bibliográficos
Autores principales: Vizarraga, David, Kawamoto, Akihiro, Matsumoto, U., Illanes, Ramiro, Pérez-Luque, Rosa, Martín, Jesús, Mazzolini, Rocco, Bierge, Paula, Pich, Oscar Q., Espasa, Mateu, Sanfeliu, Isabel, Esperalba, Juliana, Fernández-Huerta, Miguel, Scheffer, Margot P., Pinyol, Jaume, Frangakis, Achilleas S., Lluch-Senar, Maria, Mori, Shigetarou, Shibayama, Keigo, Kenri, Tsuyoshi, Kato, Takayuki, Namba, Keiichi, Fita, Ignacio, Miyata, Makoto, Aparicio, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560827/
https://www.ncbi.nlm.nih.gov/pubmed/33057023
http://dx.doi.org/10.1038/s41467-020-18777-y
Descripción
Sumario:Mycoplasma pneumoniae is a bacterial human pathogen that causes primary atypical pneumonia. M. pneumoniae motility and infectivity are mediated by the immunodominant proteins P1 and P40/P90, which form a transmembrane adhesion complex. Here we report the structure of P1, determined by X-ray crystallography and cryo-electron microscopy, and the X-ray structure of P40/P90. Contrary to what had been suggested, the binding site for sialic acid was found in P40/P90 and not in P1. Genetic and clinical variability concentrates on the N-terminal domain surfaces of P1 and P40/P90. Polyclonal antibodies generated against the mostly conserved C-terminal domain of P1 inhibited adhesion of M. pneumoniae, and serology assays with sera from infected patients were positive when tested against this C-terminal domain. P40/P90 also showed strong reactivity against human infected sera. The architectural elements determined for P1 and P40/P90 open new possibilities in vaccine development against M. pneumoniae infections.